Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  24.50 1.3% 1,914.00 1,915.00 1,916.00 1,925.00 1,890.00 1,899.00 274,051 16:35:03
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1,623.2 229.8 91.7 21.5 4,631

Hikma Pharmaceuticals Plc Director/PDMR Shareholding

17/05/2019 3:33pm

UK Regulatory (RNS & others)


Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart

1 Year : From Dec 2018 to Dec 2019

Click Here for more Hikma Pharmaceuticals Charts.

TIDMHIK

RNS Number : 4586Z

Hikma Pharmaceuticals Plc

17 May 2019

Hikma Pharmaceuticals PLC - EIP Awards

LONDON, 17 May 2019: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK)

(LEI: 549300BNS685UXH4JI75) announces that the Remuneration Committee made the following conditional awards under the Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan (the "EIP") to Persons Discharging Managerial Responsibility ("PDMR") of the Company.

Awards under the EIP were made on 12 March 2019 at a price of 1,763 pence per Ordinary Share (being the average price for the 30-day period prior to 31 December 2018, in accordance with the EIP rules) as follows:

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Said Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element B of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element B EIP award will 
                                 vest after 2 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 61,666 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Said Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Said Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element C of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element C EIP award will 
                                 vest after 3 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 38,862 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Sigurdur Olafsson

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Sigurdur Olafsson 
 2    Reason for the notification 
 a)   Position/status           Chief Executive Officer 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element B of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element B EIP award will 
                                 vest after 2 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 67,307 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Sigurdur Olafsson

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Sigurdur Olafsson 
 2    Reason for the notification 
 a)   Position/status           Chief Executive Officer 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element C of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element C EIP award will 
                                 vest after 3 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 42,676 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Sigurdur Olafsson

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Sigurdur Olafsson 
 2    Reason for the notification 
 a)   Position/status           Chief Executive Officer 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 a bespoke arrangement in respect of the first 
                                 year of service only that operates on the same 
                                 basis as Element C of the 2014 Executive Incentive 
                                 Plan (EIP). Shares will vest after 3 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 72,000 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Mazen Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Mazen Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Vice Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element B of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element B EIP award will 
                                 vest after 2 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 42,572 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Mazen Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Mazen Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Vice Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element C of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element C EIP award will 
                                 vest after 3 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 26,514 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Bassam Kanaan

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Bassam Kanaan 
 2    Reason for the notification 
 a)   Position/status           EVP, Corporate Development and M&A 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element B of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element B EIP award will 
                                 vest after 2 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 27,193 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Bassam Kanaan

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Bassam Kanaan 
 2    Reason for the notification 
 a)   Position/status           EVP, Corporate Development and M&A 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element C of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element C EIP award will 
                                 vest after 3 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 19,195 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Khalid Nabilsi

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Khalid Nabilsi 
 2    Reason for the notification 
 a)   Position/status           Chief Financial Officer 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element B of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element B EIP award will 
                                 vest after 2 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 25,089 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Khalid Nabilsi

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Khalid Nabilsi 
 2    Reason for the notification 
 a)   Position/status           Chief Financial Officer 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element C of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element C EIP award will 
                                 vest after 3 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 17,710 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Riad Mishlawi

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Riad Mishlawi 
 2    Reason for the notification 
 a)   Position/status           President, Injectables 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element B of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element B EIP award will 
                                 vest after 2 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 32,027 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Riad Mishlawi

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Riad Mishlawi 
 2    Reason for the notification 
 a)   Position/status           President, Injectables 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element C of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element C EIP award will 
                                 vest after 3 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 23,030 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Majda Labadi

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Majda Labadi 
 2    Reason for the notification 
 a)   Position/status           EVP, Organisational Development 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element B of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element B EIP award will 
                                 vest after 2 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 17,091 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Majda Labadi

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Majda Labadi 
 2    Reason for the notification 
 a)   Position/status           EVP, Organisational Development 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element C of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element C EIP award will 
                                 vest after 3 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 12,064 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Susan Ringdal

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Susan Ringdal 
 2    Reason for the notification 
 a)   Position/status           EVP, Strategic Planning and Global Affairs 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element B of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element B EIP award will 
                                 vest after 2 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 14,454 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Susan Ringdal

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Susan Ringdal 
 2    Reason for the notification 
 a)   Position/status           EVP, Strategic Planning and Global Affairs 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element C of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element C EIP award will 
                                 vest after 3 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 10,203 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Brian Hoffmann

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Brian Hoffmann 
 2    Reason for the notification 
 a)   Position/status           President, US Generics 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element B of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element B EIP award will 
                                 vest after 2 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 15,987 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Brian Hoffmann

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Brian Hoffmann 
 2    Reason for the notification 
 a)   Position/status           President, US Generics 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element C of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element C EIP award will 
                                 vest after 3 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 11,285 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Henriette Nielsen

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Henriette Nielsen 
 2    Reason for the notification 
 a)   Position/status           EVP, Business Operations 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element B of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element B EIP award will 
                                 vest after 2 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 9,902 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Henriette Nielsen

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Henriette Nielsen 
 2    Reason for the notification 
 a)   Position/status           EVP, Business Operations 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             The Company granted the named individual above 
       transaction               a conditional award to acquire Shares under 
                                 Element C of the 2014 Executive Incentive Plan 
                                 (EIP). Shares under Element C EIP award will 
                                 vest after 3 years. 
 c)   Price(s) and              Price(s): GBP17.63 
       volume(s)                 Volume(s): 6,990 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   12 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBSGDUBXBBGCR

(END) Dow Jones Newswires

May 17, 2019 10:33 ET (14:33 GMT)

1 Year Hikma Pharmaceuticals Chart

1 Year Hikma Pharmaceuticals Chart

1 Month Hikma Pharmaceuticals Chart

1 Month Hikma Pharmaceuticals Chart
Your Recent History
LSE
HIK
Hikma Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191208 20:30:50